235 related articles for article (PubMed ID: 30710547)
1. Beneficial effects of rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, in a mouse allergic asthma model is not associated with the recruitment or generation of Foxp3-expressing CD4
Maślanka T; Otrocka-Domagała I; Zuśka-Prot M; Gesek M
Eur J Pharmacol; 2019 Apr; 848():30-38. PubMed ID: 30710547
[TBL] [Abstract][Full Text] [Related]
2. IκB kinase β inhibitor, IMD-0354, prevents allergic asthma in a mouse model through inhibition of CD4(+) effector T cell responses in the lung-draining mediastinal lymph nodes.
Maślanka T; Otrocka-Domagała I; Zuśka-Prot M; Mikiewicz M; Przybysz J; Jasiecka A; Jaroszewski JJ
Eur J Pharmacol; 2016 Mar; 775():78-85. PubMed ID: 26868187
[TBL] [Abstract][Full Text] [Related]
3. Effect of inhaled and systemic glucocorticoid treatment on CD4
Zuśka-Prot M; Maślanka T
Int Immunopharmacol; 2017 Apr; 45():98-109. PubMed ID: 28189974
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma.
Zhao Y; Huang Y; He J; Li C; Deng W; Ran X; Wang D
Immunol Lett; 2014; 157(1-2):9-15. PubMed ID: 24269293
[TBL] [Abstract][Full Text] [Related]
5. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model.
Wei Y; Luo QL; Sun J; Chen MX; Liu F; Dong JC
J Ethnopharmacol; 2015 Apr; 164():368-77. PubMed ID: 25625352
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab ameliorates OVA-induced airway inflammation in mice: Role of CD4(+) CD25(+) FOXP3(+) regulatory T-cells.
Elsakkar MG; Sharaki OA; Abdallah DM; Mostafa DK; Shekondali FT
Eur J Pharmacol; 2016 Sep; 786():100-108. PubMed ID: 27262379
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.
Hammad H; de Heer HJ; Soullié T; Angeli V; Trottein F; Hoogsteden HC; Lambrecht BN
Am J Pathol; 2004 Jan; 164(1):263-71. PubMed ID: 14695339
[TBL] [Abstract][Full Text] [Related]
8. Phenotype analyses of IL-10-producing Foxp3
Matsuda M; Morie Y; Oze H; Doi K; Tsutsumi T; Hamaguchi J; Inaba M; Nabe T
Int Immunopharmacol; 2018 Aug; 61():297-305. PubMed ID: 29909233
[TBL] [Abstract][Full Text] [Related]
9. Foxp3(+)-Treg cells enhanced by repeated low-dose gamma-irradiation attenuate ovalbumin-induced allergic asthma in mice.
Park BS; Hong GU; Ro JY
Radiat Res; 2013 May; 179(5):570-83. PubMed ID: 23560633
[TBL] [Abstract][Full Text] [Related]
10. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
Sandoval P; Loureiro J; González-Mateo G; Pérez-Lozano ML; Maldonado-Rodríguez A; Sánchez-Tomero JA; Mendoza L; Santamaría B; Ortiz A; Ruíz-Ortega M; Selgas R; Martín P; Sánchez-Madrid F; Aguilera A; López-Cabrera M
Lab Invest; 2010 Oct; 90(10):1517-32. PubMed ID: 20531289
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Attenuates Allergic Asthma and Associated Inflammation in the Lungs Through Regulation of miRNA-34a That Targets FoxP3 in Mice.
Alharris E; Alghetaa H; Seth R; Chatterjee S; Singh NP; Nagarkatti M; Nagarkatti P
Front Immunol; 2018; 9():2992. PubMed ID: 30619345
[TBL] [Abstract][Full Text] [Related]
12. Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma.
Lee HY; Rhee CK; Kang JY; Park CK; Lee SY; Kwon SS; Kim YK; Yoon HK
Korean J Intern Med; 2016 Jan; 31(1):89-97. PubMed ID: 26767862
[TBL] [Abstract][Full Text] [Related]
13. Imperatorin exerts antiallergic effects in Th2-mediated allergic asthma via induction of IL-10-producing regulatory T cells by modulating the function of dendritic cells.
Lin CL; Hsiao G; Wang CC; Lee YL
Pharmacol Res; 2016 Aug; 110():111-121. PubMed ID: 27185659
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone attenuates allergic inflammation and induces production of regulatory T lymphocytes.
Wang W; Zhu Z; Zhu B; Ma Z
Am J Rhinol Allergy; 2010; 24(6):454-8. PubMed ID: 21144225
[TBL] [Abstract][Full Text] [Related]
15. Luteolin attenuates airway inflammation by inducing the transition of CD4
Kim SH; Saba E; Kim BK; Yang WK; Park YC; Shin HJ; Han CK; Lee YC; Rhee MH
Eur J Pharmacol; 2018 Feb; 820():53-64. PubMed ID: 29225189
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
Park SJ; Lee KS; Kim SR; Min KH; Choe YH; Moon H; Chae HJ; Yoo WH; Lee YC
J Immunol; 2009 Sep; 183(5):3259-67. PubMed ID: 19641141
[TBL] [Abstract][Full Text] [Related]
17. In-vivo antioxidant and anti-inflammatory activity of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists in animal model of bronchial asthma.
El-Naa MM; El-Refaei MF; Nasif WA; Abduljawad SH; El-Brairy AI; El-Readi MZ
J Pharm Pharmacol; 2015 Oct; 67(10):1421-30. PubMed ID: 26099551
[TBL] [Abstract][Full Text] [Related]
18. Critical roles of regulatory B and T cells in helminth parasite-induced protection against allergic airway inflammation.
Gao X; Ren X; Wang Q; Yang Z; Li Y; Su Z; Li J
Clin Exp Immunol; 2019 Dec; 198(3):390-402. PubMed ID: 31397879
[TBL] [Abstract][Full Text] [Related]
19. Repeated bouts of aerobic exercise enhance regulatory T cell responses in a murine asthma model.
Lowder T; Dugger K; Deshane J; Estell K; Schwiebert LM
Brain Behav Immun; 2010 Jan; 24(1):153-9. PubMed ID: 19781626
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice.
Cheng Y; Li S; Wang M; Cheng C; Liu R
Med Sci Monit; 2018 Dec; 24():9045-9053. PubMed ID: 30544130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
